5,424 Astera Labs, Inc. $ALAB Shares Bought by Bokf Na

Key Points

• Bokf Na increased its Astera Labs stake by 92.4% in the third quarter, buying 5,424 additional shares and bringing its holdings to 11,296 shares worth approximately $4.02 million.
• Institutional investors own 60.47% of Astera Labs, while insiders sold 408,558 shares valued at $127.3 million over the past 90 days.
• Analysts maintain a generally positive outlook, with an average “Moderate Buy” rating and a $340.79 price target. Astera Labs also reported quarterly revenue growth of 104.5% year over year and earnings above consensus estimates.

Bokf Na boosted its position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 92.4% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,296 shares of the company's stock after purchasing an additional 5,424 shares during the quarter. Bokf Na's holdings in Astera Labs were worth $4,021,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in ALAB. BlackRock Inc. acquired a new stake in Astera Labs in the 2nd quarter worth about $6,609,581,000. Bank of America Corp DE acquired a new stake in shares of Astera Labs in the second quarter valued at approximately $1,061,791,000. Atreides Management LP boosted its stake in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company's stock valued at $368,890,000 after buying an additional 1,754,593 shares during the period. Amundi boosted its stake in shares of Astera Labs by 77.9% in the first quarter. Amundi now owns 1,880,830 shares of the company's stock valued at $206,139,000 after buying an additional 823,477 shares during the period. Finally, Deutsche Bank AG bought a new stake in shares of Astera Labs in the second quarter valued at approximately $325,602,000. Institutional investors own 60.47% of the company's stock.

Insiders Place Their Bets

In related news, General Counsel Philip Mazzara sold 6,801 shares of the firm's stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares of the company's stock, valued at $32,872,551. This trade represents a 6.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total value of $3,382,283.64. Following the transaction, the director directly owned 2,648 shares in the company, valued at $995,806.88. The trade was a 77.25% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 408,558 shares of company stock valued at $127,306,034 over the last ninety days. 10.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research firms have commented on ALAB. Royal Bank Of Canada raised their price objective on Astera Labs from $425.00 to $500.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 5th. Jefferies Financial Group raised their target price on shares of Astera Labs from $270.00 to $450.00 and gave the company a "buy" rating in a report on Wednesday, August 5th. Needham & Company LLC upped their price target on shares of Astera Labs from $260.00 to $425.00 and gave the stock a "buy" rating in a report on Wednesday, August 5th. Morgan Stanley boosted their price objective on shares of Astera Labs from $240.00 to $335.00 and gave the company an "overweight" rating in a research report on Monday, August 3rd. Finally, Roth Capital reaffirmed a "buy" rating and issued a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Eleven equities research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $340.79.

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $290.43 on Friday. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The firm has a market cap of $50.39 billion, a PE ratio of 143.78 and a beta of 3.68. The company has a 50 day simple moving average of $308.75 and a 200 day simple moving average of $254.55.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts' expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company's revenue was up 104.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts anticipate that Astera Labs, Inc. will post 2.71 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.